# EDGAR Filing Document

**Accession Number:** 0001720215
**File Stem:** 0001720215-26-000003
**Filing Date:** 2026-4
**Character Count:** 10978
**Document Hash:** c96a50e615f4fa2c46da3d929b08d40d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001720215-26-000003.hdr.sgml**: 20260406

**ACCESSION NUMBER**: 0001720215-26-000003

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260406

**DATE AS OF CHANGE**: 20260406

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Vicarious Surgical Inc.
- **CENTRAL INDEX KEY:** 0001812173
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92092
- **FILM NUMBER:** 26842520

**BUSINESS ADDRESS:**
- **STREET 1:** 78 FOURTH AVENUE
- **CITY:** WALTHAM
- **STATE:** MA
- **ZIP:** 02451
- **BUSINESS PHONE:** (617) 868-1700

**MAIL ADDRESS:**
- **STREET 1:** 78 FOURTH AVENUE
- **CITY:** WALTHAM
- **STATE:** MA
- **ZIP:** 02451

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** D8 Holdings Corp.
- **DATE OF NAME CHANGE:** 20200514
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Innovation Endeavors III LP
- **CENTRAL INDEX KEY:** 0001720215

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 10 EAST 53RD STREET, 14TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** 212-937-9095

**MAIL ADDRESS:**
- **STREET 1:** 10 EAST 53RD STREET, 14TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**Vicarious Surgical Inc.**

*(Name of Issuer)*

**Class A Common Stock, par value $0.0001 per share**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Rebecca Lucia**<br>c/o Innovation Endeavors<br>1845 El Camino Real<br>Palo Alto CA 94306<br>(650) 644-6822

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**04/02/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Innovation Endeavors III LP** | Name of reporting person<br>**Innovation Endeavors III LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**CAYMAN ISLANDS** | Citizenship or place of organization<br>**CAYMAN ISLANDS** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**221038.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**221038.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**221038.00** | Aggregate amount beneficially owned by each reporting person<br>**221038.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**3.4%** | Percent of class represented by amount in Row (11)<br>**3.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Dror Berman** | Name of reporting person<br>**Dror Berman** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**AF** | Source of funds (See Instructions)<br>**AF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**221038.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**221038.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**221038.00** | Aggregate amount beneficially owned by each reporting person<br>**221038.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**3.4%** | Percent of class represented by amount in Row (11)<br>**3.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**HC** | Type of Reporting Person (See Instructions)<br>**HC** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Class A Common Stock, par value $0.0001 per share

**(b) Name of Issuer:**
Vicarious Surgical Inc.

**(c) Address of Issuer's Principal Executive Offices:**
78 Fourth Avenue, Waltham, MA, 02451

This Amendment No. 1 (this "Amendment No. 1" or this "Schedule 13D/A") amends and supplements the statement on Schedule 13D originally filed with the Securities and Exchange Commission (the "SEC") on September 28, 2021 (the "Statement") by the Reporting Persons. Unless otherwise defined herein, capitalized terms used in this Amendment No. 1 shall have the meanings ascribed to them in the Statement. Unless amended or supplemented below, the information in the Statement remains unchanged.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Rows 11 and 13 of each Reporting Person's cover page to this Schedule 13D set forth the aggregate number of shares of Class A common stock and percentages of the shares of Class A common stock beneficially owned by such Reporting Person and are incorporated by reference. The percentage set forth in each row 13 is based upon 6,470,228 shares of Class A common stock outstanding as of March 16, 2026, as reported in the Issuer's definitive proxy statement, filed with the SEC on March 23, 2026.

The Reporting Persons' beneficial ownership of the Issuer's securities includes 221,038 shares of Class A common stock directly held by Innovation Endeavors. Mr. Berman is a managing partner at Innovation Endeavors and shares voting and investment authority over the shares held by Innovation Endeavors.

**(b)**
Rows 7 through 10 of each Reporting Person's cover page to this Schedule 13D set forth the number of shares of Class A common stock as to which such Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition and are incorporated by reference.

**(c)**
Except as set forth below, none of the Reporting Persons has effected any transactions with respect to the securities of the Issuer during the past sixty days.

On March 20, 2026, Innovation Endeavors sold an aggregate of 10,774 shares in open market transactions at prices ranging from $1.05 to $1.11 (weighted average sales price of $1.06 per share).

On March 23, 2026, Innovation Endeavors sold an aggregate of 25,000 shares in open market transactions at prices ranging from $1.00 to $1.05 (weighted average sales price of $1.00 per share).

On March 24, 2026, Innovation Endeavors sold an aggregate of 1,001 shares in open market transactions at prices ranging from $0.95 to $1.00 (weighted average sales price of $0.95 per share).

On March 25, 2026, Innovation Endeavors sold an aggregate of 25 shares in an open market transaction at a price of $1.00 per share.

On March 26, 2026, Innovation Endeavors sold an aggregate of 3,013 shares in open market transactions at prices ranging from $0.85 to $1.00 (weighted average sales price of  $0.91 per share).

On March 27, 2026, Innovation Endeavors sold an aggregate of 1,000 shares in open market transactions at prices ranging from $0.70 to $0.72 (weighted average sales price of $0.70 per share).

On March 30, 2026, Innovation Endeavors sold an aggregate of 4,595 shares in open market transactions at prices ranging from $0.80 to $0.81 (weighted average sales price of $0.80 per share).

On March 31, 2026, Innovation Endeavors sold an aggregate of 1,449 shares in open market transactions at prices ranging from $0.71 to $0.83 (weighted average sales price of  $0.76 per share).

On April 1, 2026, Innovation Endeavors sold an aggregate of 1,487 shares in open market transactions at prices ranging from $0.65 to $0.88 (weighted average sales price of $0.80 per share).

On April 2, 2026, Innovation Endeavors sold an aggregate of 53,868 shares in open market transactions at prices ranging from $0.72 to $0.83 (weighted average sales price of $0.78 per share).

On April 6, 2026, Innovation Endeavors sold an aggregate of 136,682 shares in open market transactions at prices ranging from $0.78 to $0.85 (weighted average sales price of $0.82 per share).

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Innovation Endeavors III LP

**Signature:** /s/ Dror Berman

**Name/Title:** By Dror Berman, Managing Partner

**Date:** 04/06/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Dror Berman

**Signature:** /s/ Dror Berman

**Name/Title:** Dror Berman

**Date:** 04/06/2026